Clinical Trials
97 Articles
More Effective Radiotherapy for Advanced Pancreatic Cancer Patients
Researchers are testing a drug that penetrates the stroma, to make radiotherapy work better for advanced pancreatic cancer patients.
Managing Metastatic Pancreatic Cancer with Chemotherapy and Diet
A new clinical trial looks at a special diet that tries to curb a patient’s metabolism to slow cancer growth during chemotherapy.
Report Highlights Potential of TCR Therapy
Dr. Elizabeth Jaffee explains the unique technique used with success for one patient in a new immunotherapy clinical trial.
Four-Drug Combination Tested in Metastatic Pancreatic Cancer
A clinical trial is testing a drug combination including a drug used for erectile dysfunction, a new drug, and two immunotherapy drugs.
Surprising Clinical Trial Results in Pancreatic and Rectal Cancer
Let’s Win Scientific Advisory Board Chair Dr. Allyson Ocean explains the surprising clinical trial results in pancreatic and rectal cancers.
Chemotherapy-Radiation Combination for Pancreatic Cancer in the Liver
Can targeted radiation disrupt tumor growth in the liver of advanced pancreatic cancer patients with BRCA2 and PALB2 mutations?
KRYSTAL-1 Trial Shows Promising Activity in Pancreas and Other GI Cancers
Dr. Tanios Bekaii-Saab reports promising results of the KRYSTAL-1 trial, which targets a KRAS mutation common to pancreatic cancer.
Testing a Thyroid Cancer Drug to Treat Advanced Pancreatic Neuroendocrine Tumors
Researchers are testing a thyroid drug to see if it is effective against pancreatic neuroendocrine tumors, among other cancers.
New Trial to Find Biomarkers to Guide Treatment
Drs. Jennifer Knox and Elizabeth Jaffee lead the PASS-01 trial using biomarkers and other measures to choose individualized treatment.
Platform Trial Design Aims to Get Information Quickly and Efficiently
Dr. Eugene Koay is leading a platform trial, for a more nimble way to adapt to participants’ response to treatments being tested.
Modifying the Tumor Microenvironment to Make Treatment More Effective
Researchers are testing a new drug that better-allows chemotherapy to penetrate the tumor microenvironment of pancreatic cancer.
New Clinical Accelerator Initiative Shortens Time from Bench to Clinic
Dr. Elizabeth Jaffee explains the importance of Lustgarten’s Clinical Accelerator Initiative to speed up the time from bench to trial.
Testing a Combination for Metastatic Pancreatic Cancer
A clinical trial tests an investigational drug, immunotherapy, and radiation in combination against advanced pancreatic cancer.
Large Phase III Global Trial Targets Cancer Metabolism
Dr. Philip Philip focuses on disrupting cancer cell metabolism with devimistat, now in a phase III global clinical trial.
CRISPR-Engineered Immunotherapy for Metastatic GI Tract Cancers
CRISPR technology is used as part of an immunotherapy clinical trial for metastatic pancreatic cancer and other GI cancers.